Pgp is believed to be responsible for the MDR phenotype in most cancers [109,111], as it is a protein capable of actively pumping various drugs (e.g., DOX, vinblastine and PTX) out of the cell, thus reducing their cytotoxic efficacy [108]. The gene discussed is PGP; the disease is cancer.